IntroductionThe use of genes as medicine gives rise to the concept of "gene therapy". In the process of gene therapy, a defective gene copy is repaired by transmitting the therapeutic gene copy to an individual's cells. Therefore, a faulty gene could be replaced or a medical condition could be corrected by introducing a new gene. Gene therapy has a promising future as it is powerful enough to treat many genetic conditions and also other deadly diseases like AIDS, cancer, etc. Although the potential of "gene therapy" is realized and recognized, it still remains at an experimental level and needs work before it is accepted as the best solution. Gene therapy was put into practice in the 1990s to treat the immunodeficiency disease called ADA "adenosine deaminase" deficiency. This is when genetic transmission of "corrective genes" into stem cells first occurred in practice. MethodThe task of making gene therapy work with positive results is considerable. To put this into practice, we must first understand the defect in question and identify the faulty genes in the system. Beyond that, the identified defective genes should be accessible, the appropriate healthy or healing gene set should be made available, and finally a way to deliver this gene to that defective area must be clearly constructed. The final part is the most challenging procedure in the gene therapy process. “Gene Delivery” tells you how to get the healing gene to reach the defective area. Few of these vectors would help us with the "gene transfer" problem. a) Harmless viruses A favorable method for "gene transfer" would be to use harmless viruses as gene carriers into cells. This method is not... middle of paper... cannot be given credence in light of what is currently known, engineered personalities, master races, or Frankenstein's monsters. The best insurance against possible abuse is a well-informed public. With the adequate guarantees offered by the scientific society, this powerful therapeutic procedure would provide great benefits by reducing the suffering and death caused by genetic diseasesWorks cited[1] Aiuti A, Cattaneo F, Galimberti S et al. (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. New England[2] Journal of Medicine 360:447-458.[3] The Gene Therapy Research Unit, The Children's Hospital, Westmead, Australia [online].[4] Available from: http://www.chw.edu.au/prof/services/genetherapy/ [Accessed February 2014].[5] http://www.extremetech.com/ [Accessed March 2014].[6] http://ghr.nlm.nih.gov/handbook/therapy/ethics